Abstract
In order to study potential changes in phosphodiesterase (PDE) activity associated with malignant transformation, normal primary keratinocytes and cells corresponding to different stages of epidermal tumor development in mouse skin were analyzed with respect to their 3′,5′-cyclic adenosine monophosphate (cAMP) hydrolyzing activity. Expression of cAMP-specific PDE-4, intracellular cAMP content, and the sensitivity to the growth inhibitory effect of the PDE-4-specific inhibitor 7-benzylamino-6-chloro-2 piperazino-4-pyrrolidino-pteridine (DC-TA-46) were studied in the two papilloma cell lines, MSCP6 and 308, and in the highly malignant carcinoma cell line CarB. No significant difference in soluble PDE activity and in intracellular cAMP was found in the two papilloma cell lines when compared to primary keratinocytes. In contrast, the spindle-cell carcinoma cell line CarB exhibited significantly higher PDE activity, concomitant with the lowest cAMP level. In all cell lines and also in the primary keratinocytes, rolipram-sensitive PDE-4 activity accounted for the major cAMP-hydrolyzing activity. In primary keratinocytes and in MSCP6 cells, the PDE-4 inhibitor DC-TA-46 induced at best marginal growth inhibition, whereas cell growth of 308 cells was markedly affected at concentrations >2 μM. The carcinoma cell line CarB showed the highest sensitivity to DC-TA-46 (IC50=0.8±0.3 μM). Treatment of CarB cells with DC-TA-46 strongly inhibits intracellular PDE activity, resulting in a marked and long-lasting rise of cAMP. After 24 h of treatment, arrest in the G0/G1 phase of the cell cycle is induced. Treatment with concentrations >2 μM of this highly effective PDE inhibitor results in induction of apoptotic cell death, as detected by fluorescence microscopy, flow cytometry, and ELISA-based determination of fragmented DNA in intact cells.
Similar content being viewed by others
Abbreviations
- cAMP:
-
cyclic adenosine monosphosphate
- cGMP:
-
cyclic guanosine monophosphate
- DAPI:
-
4′,6-diamidino-2-phenylindol-dihydrochloride
- DC-TA-46:
-
7-benzylamino-6-chloro-2-piperazino-4-pyrrolidino-pteridine
- DMBA:
-
7,12-dimeth ylbenz(a)anthracene
- EHNA:
-
erythro-9-(2-hydroxy-3-nonyl) adenine
- Milrinone:
-
1,6-dihydro-2-methyl-6-oxo-(3,4′-bipyridine)-5-carbonitril
- Motapizone:
-
4,5-dihydro-6-(4-[1H-imidazol-1-yl]-2-thienyl)-5-methyl-3-(2H)-pyridazinone
- NCS:
-
newborn calf serum
- PDE:
-
phosphodiesterase
- RO 20-1724:
-
4-(3-butoxy-4-methoxybenzyl)-2-imidazolidone
- rolipram:
-
4-(3-cyclopentyloxy-4-methoxyphenyl)-2-pyrrolidone
- SR 101:
-
Sulforhodamine 101
- SRB:
-
sulforhodamine B
- TPA:
-
12-O-tetradecanoyl-phorbol-13-acetate
- vinpocetine:
-
14-eburnamenine-carboxylic acid ethyl ester
- zaprinast:
-
2-O-propoxyphenyl-8-azapurin-6-one
References
Drees, M., Zimmermann, R., and Eisenbrand, G. (1993) 3′,5′-Cyclic nucleotide phosphodiesterase in tumor cells as potential target for tumor growth inhibition.Cancer Res. 53, 3058–3061.
McConkey, D. J., Jondal, M., and Orrenius, S. (1992) Cellular signaling in thymocyte apoptosis.Semin. Immunol. 4, 371–377.
McConkey, D. J., Orrenius, S., and Jondal, M. (1990) Agents that elevate cAMP stimulate DNA fragmentation in thymocytes.J. Immunol. 145(4), 1227–1230.
Jiang, X., Li, J., Paskind, M., and Epstein, P. M. (1996) Inhibition of calmodulin-dependent phosphodiesterase induces apoptosis in human leukemic cells.Proc. Natl. Acad. Sci. USA 93, 11,236–11,241.
Boyton, A. L. and Whitfield, J. F. (1983) The role of cyclic AMP in cell proliferation: a critical assessment of the evidence.Adv. Cyclic Nucleotide Res. 15, 193–294.
Lando, M., Abemayor, E., Verity, M. A., and Sidell, N. (1990) Modulation of intracellular cyclic adenosine monophosphate levels and the differentiation response of human neuroblastoma cells.Cancer Res. 50, 722–727.
Hickie, R. A., Walker, C. M., and Crolli, G. A. (1974) Decreased basal cyclic adenosine 3′, 5′-monophosphate levels in Morris hepatoma 5123 T.C.Biochem. Biophys. Res. Commun. 59, 167–173.
Gottesman, M. M. and Fleischmann, R. D. (1986) The role of cAMP in regulating tumour cell growth.Cancer Surveys 5(2), 291–308.
Monaco, L., Vicini, E., and Conti, M. (1994) Structure of two rat genes coding for closely related Rolipram-sensitive cAMP phosphodiesterases.J. Biol. Chem. 269(1), 347–357.
Beavo, J. A., Conti, M., and Heaslip, R. J. (1994) Multiple cyclic nucleotide phosphodiesterases.Mol. Pharmacol. 46, 399–405.
Beavo, J. A. and Reifnyder, D. H. (1990) Primary sequence of cyclic nucleotide phosphodiesterase isoenzymes and the design of selective inhibitors.Trends Pharmacol. Sci. 11, 150–155.
Conti, M., Nemoz, G., Sette, C., and Vicini, E. (1995) Recent progress in understanding the hormonal regulation of phosphodiesterases.Endocr. Rev. 16(3), 370–389.
Wells, J. N. and Miller, J. R. (1988) Methylxanthine inhibitors of phosphodiesterase.Methods Enzymol. 159, 489–496.
Podzuweit, T., Nennstiel, P., and Müller, A. (1995) Isoenzyme selective inhibition of cGMP-stimulated cyclic nucleotide phosphodiesterases by erythro-9-(2-hydroxy-3-nonyl)adenine.Cell. Signal. 7(7), 733–738.
Méry, P.-F., Pavoine, C., Pecker, F., and Fischmeister, R. (1995) Erythro-9-(2-hydroxy-3-nonyl)adenine inhibits cyclic GMP-stimulated phosphodiesterase in isolated cardiac myocytes.Mol. Pharmacol. 48, 121–130.
Michie, A. M., Lobban, M., Müller, T., Harnett, M. M., and Houslay, M. D. (1996) Rapid regulation of PDE-2 and PDE-4 cyclic AMP phosphodiesterase activity following ligation of the T cell antigen receptor on thy-mocytes: analysis using the selective inhibitors erythro-9-(2-hydroxy-3-nonyl)-adenine (EHNA) and Rolipram.Cell. Signal. 8(2), 97–110.
Harrison, S. A., Reifsnyder, D. H., Gallis, B., Cadd, G. G., and Beavo, J. A. (1986) Isolation and characterization of bovine cardiac muscle cGMP-inhibited phosphodiesterase: a receptor for new cardiotonic drugs.Mol. Pharmacol. 29, 506–514.
Singh, B., Bacon, E. R., Lesher, G. Y., Shaughnessy, R., Pennock, P. O., Bode, D. C., Pagani, E. D., Bentley, R. G., Connell, M. J., Hamel, L. T., and Silver, P. J. (1995) Novel and potent adenosine 3′,5′-cyclic phosphate phosphodiesterase III inhibitors: Thiazolo[4,5-b][1,6] naphthyridin-2-ones.J. Med. Chem. 38, 2546–2550.
Bolger, G. B. (1994) Molecular biology of the cyclic AMP-specific cyclic nucleotide phosphodiesterases: a diverse family of regulatory enzymes.Cell. Signal. 6(8), 851–859.
Gillespie, P. G. and Beavo, J. A. (1989) Inhibition and stimulation of photoreceptor phosphodiesterase by dipyridamole and M&B 22,948.Mol. Pharmacol. 36, 773–781.
Michaeli, T., Bloom, T. J., Martins, T., Loughney, K., Ferguson, K., Riggs, M., Rodgers, L., Beavo, J. A., and Wigler, M. (1993) Isolation and characterization of a previously undetected human cAMP phosphodiesterase by complementation of cAMP phosphodiesterase-deficient saccharomyces cervisiae.J. Biol. Chem. 268(17), 12,925–12,932.
Bloom, J. T. and Beavo, J. A. (1996) Identification and tissue-specific expression of PDE7 phosphodiesterase splice variants.Proc. Natl. Acad. Sci. USA 93, 14,188–14,192.
Fürstenberger, G. and Kopp-Schneider, A. (1995) Malignant progression of papillomas induced by the initiation-promotion protocol in NMRI mouse skin.Carcinogenesis 16, 61–69.
Stoler, A. B., Stenback, F., and Balmain, A. (1993) The conversion of mouse skin squamous cell carcinomas to spindle cell carcinomas is a recessive event.J. Cell. Biol. 122, 1103–1117.
Marks, F. and Fürstenberger, G. (1995) Tumor promotion in skin, inChemical Induction of Cancer: Modulation and Combination Effects (Arcos, J., ed.), Birkhäuser, Boston, pp. 125–160.
Kulesz-Martin, M., Kilkenny, A. E., Holbrook, K. A., Digernes, V., and Stuart, H. Y. (1993) Properties of carcinogen altered mouse epidermal cells resistant to calcium-induced terminal differentiation.Carcinogenesis 4(11), 1367–1377.
Strickland, I. E., Greenhalgh, D. A., Koceva-Chyla, A., Digernes, V., and Yuspa, S. (1983) Development of murine epidermal cell lines which contain an activated rasHa oncogene and form papillomas in skin grafts on athymic nude mouse hosts.Carcinogenesis 4, 1367–1377.
Haddow, S., Fowlis, D. J., Parkinson, K., Akhurst, R. J., and Balmain, A. (1991) Loss of growth control by TGF-b occurs at a late stage of mouse skin carcinogenesis and is independent ofras gene activation.Oncogene 6, 1465–1470.
Fürstenberger, G., Gross, M., Schweizer, J., Vogt, I., and Marks, F. (1986) Isolation, characterization, and invitro cultivation of subfractions of neonatal mouse keratinocytes: effects of phorbol esters.Carcinogenesis 7, 1745–1753.
Pöch, N. (1971) Assay of PDE with radioactively labeled cAMP as substrate. Naunyn Schmiedebergs Arch.Pharmacol. 268, 272–299.
Skehan, P., Storeng, R., Scudiero, D., Monks, A., McMahon, J., Vistica, D. Warren, J. T., Bokesch, H., Kenney, S., and Boyd, M. R. (1990) New colorometric assay for anticancer-drug screening.JNCI 82, 1107–1112.
Torphy, T. J. and Cieslinski, L. B. (1990) Characterization and selective inhibition of cyclic nucleotide phosphodiesterase isoenzymes in canine tracheal smooth muscle.Mol. Pharmacol. 37(2), 206–214.
Alvarez, R., Sette, C., Yang, D., Eglen, R. M., Wilhelm, R., Shelton, E. R., and Conti, M. (1995) Activation and selective inhibition of a cyclic AMP-specific phosphodiesterase, PDE-4D3.Mol. Pharmacol. 48, 616–622.
Millis, A. J. T., Forrest, G., and Pious, D. A. (1974) Cyclic AMP-dependent regulation of mitosis in human lymphoid cells.Exp. Cell Res. 83, 335–343.
Ralph, R. K. (1983) Cyclic AMP, calcium and control of cell growth.FEBS Lett. 161(1), 1–8.
Vintermyr, O. K., Gjertsen, B. T., Lanotte, M., and Døskeland, S. O. (1993) Microinjected catalytic subunit of cAMP-dependent protein kinase induces apoptosis in myeloid leukemia (IPC-81) cells.Exp. Cell. Res. 206, 157–161.
Okuyama, K., Iwamoto, Y., Tanaka, K., Ito, Y., and Sugioka, Y. (1994) The inhibition of the invasion of human fibrosarcoma cells by cyclic AMP analogues and cholera toxin.Cancer J. 7(4, 150–156.
Revillon, B., Vandewalle, B., Hornez, L., and Lefebvre, J. (1993) Influence of cAMP on E-cadherin expression and cell surface heparan sulfate proteoglycan synthesis in human breast cancer cells.Anticancer Res. 13, 1625–1630.
Suh, B. S., Eisenbach, L., and Amsterdam, A. (1992) Adenosine 3′,5′-monophosphate suppresses metastatic spread in nude mice of steroidogenic rat granulosa cells transformed by simian virus-40 and Ha-ras.Endocrinology 131(1), 526–532.
Tzanakakis, G. N., Agarwal, K. C., and Vezeridis, M. P. (1993) Prevention of human pancreatic cancer cell-induced hepatic metastasis in nude mice by dipyridamole and its analog RA-233.Cancer 71(8), 2466–2471.
Iwamoto, Y., Reich, R., Nemeth, G., Yamada, Y., and Martin, G. R. (1993) Cyclic AMP decreases chemotaxis, invasiveness and lung colonization of H-ras transformed mouse fibroblasts.Clin. Exp. Metastasis 11, 492–501.
Zacharski, L. R., Moritz, T. E., Baczek, L. A., Rickles, F. R., Edwards, R. L., Forman, W. B., Forcier, R. J., Cornell, C. J., Haakenson, C. M., Ballard, H. S., Crum, E. D., Johnson, G. J., Levine, J., Hong, W. K., O'Donnell, J. F., Schilsky, R. L., Ringenberg, Q. S., Robert, F., Spaulding, M. B., Tornyos, K., Williams, C., Zucker, S., Faulkner, II., C. S., Eaton, W. L., and Hoppel, C. L. (1988) Effect of Mopidamol on survival in carcinoma of the lung and colon: final report of veterans administration cooperative study No. 188.JNCI 80(2), 8–15.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Marko, D., Romanakis, K., Zankl, H. et al. Induction of apoptosis by an inhibitor of cAMP-specific PDE in malignant murine carcinoma cells overexpressing PDE activity in comparison to their nonmalignant counterparts. Cell Biochem Biophys 28, 75–101 (1998). https://doi.org/10.1007/BF02737806
Issue Date:
DOI: https://doi.org/10.1007/BF02737806